Latest Headlines

  1. Riverarch Equity Partners Announce Acquisition Of Alconox By Portfolio Company TCP Analytical 7/3/2025

    Riverarch Equity Partners (“Riverarch”) and other investors, including Audax Strategic Capital, The Hillman Company, Lacy Diversified, and PPM America, together with their portfolio company TCP Analytical are pleased to announce the acquisition of Alconox, LLC (“Alconox” or the “Company”), a leading provider of branded laboratory cleaning solutions.

  2. CAI And phData Announce Partnership To Accelerate AI-Driven Operational Readiness In Life Sciences 7/3/2025

    CAI, a global professional services firm renowned for Operational Readiness and Operational Excellence, today announced a strategic partnership with phData, a leader in data engineering and AI/ML solutions. Together, the companies will deliver intelligent, scalable technologies that help pharmaceutical and biotech manufacturers speed facility readiness, minimize operational delays, and maintain unwavering regulatory compliance. 

  3. Sandoz Breaks Announces Construction On New Drug Manufacturing Facility In Slovenia 7/2/2025

    Sandoz, the global leader in generic and biosimilar medicines, today announced the start of construction for a new, state-of-the-art biosimilars production center for sterile product manufacturing in Brnik, Slovenia.

  4. CAI And ValGenesis Partner To Deliver AI-Enabled Digital Validation For The Life Sciences Industry 7/1/2025

    CAI, a global professional services firm specializing in operational readiness for regulated industries, today announced a strategic partnership with ValGenesis, Inc., a leader in digital validation lifecycle management. Together, the companies will help life sciences organizations modernize validation processes and improve compliance through the power of artificial intelligence. 

  5. Hikma Announces $1 Billion Investment For US Drug Manufacturing Facilities 6/30/2025

    In its ongoing mission to help meet America’s growing need for high-quality US-made medicines, Hikma Pharmaceuticals USA today announces it will invest $1 billion by 2030 to further expand its US manufacturing and R&D capabilities.  This new phase of investment -- America Leans on Hikma: Quality Medicines Manufactured in the USA – will further expand Hikma’s well-established domestic capabilities to develop, produce and deliver a broad range of medicines needed by the US healthcare system to treat patients nationwide.

  6. CDMO Simtra BioPharma Solutions Completes Construction On New Fill/Finish Manufacturing Facility In Germany 6/30/2025

    Simtra BioPharma Solutions announced today that it completed the construction of its new production manufacturing building at its campus in Halle, Germany. As a leader in the CDMO industry specializing in sterile injectables, Simtra is strengthening its presence across North America and Europe to meet the growing global demand for critical injectable therapeutics.

  7. ROSS Introduces A Custom Coaxial Mixer For Complex Formulations 6/30/2025

    ROSS is pleased to announce the completion of a custom Coaxial Mixer. Through an innovative concentric-shaft configuration, this advanced system effectively blends, disperses, and homogenizes materials by combining two synergistic agitation technologies. In a variety of industries, such as adhesives, sealants, coatings, composites, cosmetics, and pharmaceuticals, the coaxial design enables processors to handle a wide range of rheologies while offering a range of different flow patterns.

  8. First Cohort Graduates Biomanufacturing Certification Program At Spokane Colleges 6/30/2025

    Ten students graduated from the inaugural Essentials in Biomanufacturing Certification program on June 26, 2025, at Spokane Colleges. Jubilant HollisterStier (JHS), a contract pharmaceutical manufacturing company, partnered with Spokane Colleges to develop this specialized training program to jumpstart careers in the growing life sciences industry.

  9. CDMO Vetter Pharma Breaks Ground On New Clinical Manufacturing Aseptic Filling Facility In Illinois 6/27/2025

    Vetter celebrated the start of construction on its new clinical manufacturing site in the Chicago area with an official groundbreaking ceremony. The state-of-the-art facility, which is being built in Des Plaines, Illinois, is expected to be ready for media fill by the end of 2029. This $285 million investment will strengthen Vetter’s position as a leading global partner for aseptic manufacturing in early clinical development.

  10. Fristam Pumps USA Welcomes Roman Andrew As Application Engineer 6/27/2025

    Fristam Pumps USA is pleased to announce the addition of Roman Andrew to its team as an Applications Engineer. In this role, Roman will provide both in-house and in-field technical support, assisting customers with pump selection, application guidance, and system troubleshooting, as well as delivering outstanding customer service.